Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Psiquiatría social: Las mujeres centroamericanas y la psiquiatría
1
x
$
0.00
M. Ojinga Harrison, MD: Antipsychotic Medications and Sudden Cardiac Death
1
x
$
30.00
Neuropsicofarmacología geriátrica: una guía sobre dosificación y monitoreo de sustancias psicotrópicas en la población geriátrica
1
x
$
0.00
Psiquiatría de enlace: Tiroides y enfermedades del ánimo
1
x
$
0.00
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
1
x
$
30.00
The 2018 Guide to Oncologic Dosing
1
x
$
30.00
Letter From the Editors: A Question of Ownership
1
x
$
0.00
Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
1
x
$
30.00
A Case Report of Stuttering Induced by Risperidone and Chlorpromazine
1
x
$
30.00
Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
1
x
$
30.00
Psiquiatría social: Diferencias de sexo y de género en la depresión: reporte de la cumbre sobre la mujer y la depresión
1
x
$
0.00
Assessment of the Correlation Between Unipolar and Bipolar Depression, Calcium Levels, Thyroid Function, and Inflammatory Markers: A Pilot Cross-Sectional Study
1
x
$
30.00
The Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention
1
x
$
30.00
Ultrasonically Determined Thyroid Volume in Individuals with Bipolar Disorder on Lithium Prophylaxis Compared with Healthy Controls
1
x
$
30.00
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
1
x
$
30.00
View Cart
Checkout
Home
Store
“Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Oncology Spectrums: Volume 2 No. 1
$
0.00
Add to cart
Details
Oncology Spectrums: Volume 2 No. 2
$
0.00
Add to cart
Details
Oncology Spectrums: Volume 2 No. 3
$
0.00
Add to cart
Details
Oncology Spectrums: Volume 2 No. 4
$
0.00
Add to cart
Details
Oncology Spectrums: Volume 2 No. 5
$
0.00
Add to cart
Details
Oncology Spectrums: Volume 2 No. 6
$
0.00
Add to cart
Details
Oncology Spectrums: Volume 2 No. 7
$
0.00
Add to cart
Details
Oncology Spectrums: Volume 2 No. 8
$
0.00
Add to cart
Details
Oncology Spectrums: Volume 2 No. 9
$
0.00
Add to cart
Details
Oncology Spectrums: Volume 2 No. 10
$
0.00
Add to cart
Details
Letter From the Editors: A Singleness of Purpose— A Spectrum of Expertise and Care— What Will the Future Bring?
$
0.00
Add to cart
Details
Publisher’s Statement: Raising Cain
$
0.00
Add to cart
Details
Pharmacy Practice: New Medicines in Development for Cancer
$
0.00
Add to cart
Details
Pharmacoeconomics of Cisplatin-Based Chemoradiation in Cervical Cancer: A Review
$
0.00
Add to cart
Details
Increased Mortality Risk Associated With Medial Breast Tumors May Be Due to Untreated Internal Mammary Node Metastases
$
0.00
Add to cart
Details
Colorectal Cancer Screening: How Are We Doing and How Can We Improve?
$
0.00
Add to cart
Details
Guest Editor: Research Needs in Myeloma
$
0.00
Add to cart
Details
Pharmacology and Therapeutic Use of Trastuzumab in Breast Cancer
$
0.00
Add to cart
Details
High-Dose Therapy in Patients with Multiple Myeloma
$
0.00
Add to cart
Details
Diagnosis and Treatment of Depression in the Cancer Patient
$
0.00
Add to cart
Details
Previous
1
…
23
24
25
…
44
Next
Page load link
Go to Top
